Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FE 999901 (Dinoprostone) Vaginal Insert for Cervical Ripening at 41 Weeks
NCT03067727Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Apr 2017
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dinoprostone in cervical ripening (CR), sponsored by Ferring Pharmaceuticals. Started Apr 2017; status: completed.
02
Drugs
dinoprostone
03
Conditions
cervical ripening (CR)
Beyond the preview
Go deeper on NCT03067727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03067727.